Extendicare Announces Voting Results for Its 2024 Annual Meeting of Shareholders
Extendicare Announces Voting Results for Its 2024 Annual Meeting of Shareholders
MARKHAM, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. ("Extendicare" or the "Company") (TSX: EXE) today announced the results of matters voted on at its annual meeting of shareholders held on May 23, 2024 (the "Meeting"). The voting results for each of the matters considered at the Meeting are presented below.
2024年5月23日,加拿大安大略省馬克姆(MARKHAM),凱宜老年護理公司(“凱宜”或“公司”)(tsx: EXE)宣佈了2024年5月23日召開的股東周年大會(“會議”)上的投票結果,以下是會議考慮的每個事項的投票結果。
The total number of common shares represented by shareholders present in person or by proxy at the Meeting was 31,858,543, representing 38.21% of the Company's outstanding common shares.
會議上在場的股東或代理人代表的普通股總數爲31,858,543股,佔公司流通普通股的38.21%。
1. Election of Directors
1. 董事選舉
On a vote by ballot, the election of eight of the following nine nominees as directors of the Company to hold office until the next annual meeting of the Company, or until their respective successors are elected or appointed, was approved. Alan Hibben did not receive a majority of votes in favour at the Meeting and thus has not been re-elected as a director of Extendicare and resigned as such effective at the end of the Meeting. The results of the vote on this matter are set out below.
在投票表決中,選出該公司九名提名董事中的八人,擔任其職位直至公司下次股東大會,或至其各自的繼任者當選或被任命,此事項已經批准。Alan Hibben在會議上沒有獲得多數贊成票,因此未能被重新選舉爲凱宜的董事,並在會議結束時辭職。此事項的投票結果如下。
Nominee | Votes For | % | Votes Against | % |
Norma Beauchamp | 31,188,526 | 99.37 | 197,524 | 0.63 |
Dr. Michael Guerriere | 31,204,369 | 99.42 | 181,681 | 0.58 |
Sandra L. Hanington | 30,752,639 | 97.98 | 633,410 | 2.02 |
Alan R. Hibben | 12,943,933 | 41.24 | 18,442,116 | 58.76 |
Brent Houlden | 31,207,781 | 99.43 | 178,269 | 0.57 |
Donna E. Kingelin | 31,148,497 | 99.24 | 237,373 | 0.76 |
Samir Manji | 30,739,166 | 97.94 | 646,884 | 2.06 |
Al Mawani | 30,724,478 | 97.89 | 661,572 | 2.11 |
Alan D. Torrie | 30,295,942 | 96.53 | 1,090,107 | 3.47 |
提名人 | 已投票支持 | % | 反對票 | % |
Norma Beauchamp | 31,188,526 | 99.37 | 197,524 | 0.63 |
Dr. Michael Guerriere | 31,204,369 | 99.42 | 181,681 | 0.58 |
Sandra L. Hanington | 30,752,639 | 97.98 | 633,410 | 2.02 |
Alan R. Hibben | 12,943,933 | 41.24 | 18,442,116 | 58.76 |
Brent Houlden | 31,207,781 | 99.43 | 178,269 | 0.57 |
Donna E. Kingelin | 31,148,497 | 99.24 | 237,373 | 0.76 |
Samir Manji | 30,739,166 | 97.94 | 646,884 | 2.06 |
Al Mawani | 30,724,478 | 97.89 | 661,572 | 2.11 |
Alan D. Torrie | 30,295,942 | 96.53 | 1,090,107 | 3.47 |
Alan joined the board of directors of Extendicare in 2016 and served as a member and chair of various committees of the board, including as Chair of the Audit Committee. Alan was steadfastly independent and forthright, but also a collaborative member who placed the interests of the Company, its shareholders and those in its care above all else. We wish him well in his future board roles. The Company will in due course commence a process to address the vacancy.
Alan於2016年加入Extendicare的董事會,並擔任董事會的各種委員會的成員和主席,包括審計委員會主席。Alan堅定地獨立和坦率,但也是一個合作的成員,將公司、股東和那些受其關照的人的利益置於首位。我們祝他未來的董事會角色一切順利。公司將適時啓動一個流程,以解決空缺。
2. Appointment of Auditors
2. 核數師的任命
On a vote by show of hands, the appointment of KPMG LLP as the auditors of the Company to hold office until the close of the next annual meeting of the Company at such remuneration as shall be fixed by the board of directors of the Company was approved. The results of the vote on this matter are set out below.
根據舉手表決的結果,KPMG LLP公司被任命爲公司的核數師,任期至公司下次年度股東大會閉幕,報酬由公司的董事會確定。關於這個問題的投票結果如下。
Votes For | % | Votes Withheld | % |
30,054,828 | 94.37 | 1,793,532 | 5.63 |
已投票支持 | % | 已投票反對 | % |
30,054,828 | 94.37 | 1,793,532 | 5.63 |
3. Approach to Executive Compensation
3. 執行薪酬的做法
On a vote by show of hands, a non-binding advisory resolution to accept the Company's approach to executive compensation disclosed in the Company's management information and proxy circular dated April 11, 2024 was approved. The results of the vote on this matter are set out below.
根據舉手表決的結果,非約束性諮詢決議獲得批准,接受公司在其管理信息和代理循環文件(日期爲2024年4月11日)中公開的執行薪酬的做法。關於這個問題的投票結果如下。
Votes For | % | Votes Against | % |
30,724,273 | 97.92 | 651,594 | 2.08 |
已投票支持 | % | 反對票 | % |
30,724,273 | 97.92 | 651,594 | 2.08 |
About Extendicare
關於Extendicare
Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. We are committed to delivering quality care throughout the health continuum to meet the needs of a growing seniors' population. We operate a network of 123 long-term care homes (52 owned/71 under management contracts), deliver approximately 10.2 million hours of home health care services annually, and provide group purchasing services to third parties representing approximately 138,300 beds across Canada. Extendicare proudly employs approximately 22,000 qualified, highly trained and dedicated team members who are passionate about providing high-quality care and services to help people live better.
Extendicare是加拿大領先的老年護理與服務提供商,旗下擁有Extendicare、ParaMed、Extendicare Assist和SGP Purchasing Partner Network品牌。我們致力於提供質量卓越的老年護理服務,以滿足逐年增長的老年人口需求。我們經營着123家長期護理機構(52家自營/71家管理合同),每年提供約1020萬小時的家庭醫療保健服務,並向整個加拿大的約138,300張牀位提供集團採購服務。Extendicare自豪地聘用了約22,000名合格、高素質、專業的團隊成員,他們熱情致力於提供高質量的護理和服務,幫助人們更好地生活。
Forward-looking Statements
前瞻性聲明
Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated future events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, growth strategy, results of operations and financial condition. Forward-looking statements can often be identified by the expressions "anticipate", "believe", "estimate", "expect", "intend", "objective", "plan", "project", "will", "may", "should" or other similar expressions or the negative thereof. These forward-looking statements reflect the Company's current expectations regarding future results, performance or achievements and are based upon information currently available to the Company and on assumptions that the Company believes are reasonable. The Company assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare's forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at and on Extendicare's website at .
Extendicare的信息(包括本文)可能包含有關Extendicare及其子公司預期未來事件、結果、情況、經濟表現或預期,包括但不限於有關其業務運營、業務策略、增長策略、營運結果和財務狀況的聲明。這些前瞻性聲明通常包括"期望"、"相信"、"估計"、"預計"、"打算"、"目標"、"計劃"、"項目"、"將要"、"可能"、"應該"或類似表達方式或其否定形式。這些前瞻性聲明反映了公司對未來結果、表現或成就的預期,並基於公司目前持有的信息和公司認爲合理的假設。公司不承擔更新或修訂任何前瞻性聲明的義務,除非適用的證券法律有要求。這些陳述不是未來表現的保證,涉及已知和未知的風險、不確定性和其他因素,可能導致公司的實際結果、表現或成就與聲明中所表達的不同。鑑於這些風險和不確定性,讀者應謹慎對待Extendicare的前瞻性聲明。更多信息可在Extendicare向證券監管機構提交的披露文件中找到,這些文件可訪問和在Extendicare的網站上獲得。
Extendicare contact:
Extendicare聯繫方式:
Jillian E. Fountain
Vice President, Investor Relations
T: (905) 470-5534
E: jfountain@extendicare.com
Jillian E. Fountain
投資者關係副總裁
電話:(905)470-5534
電子郵件:jfountain@extendicare.com